V

Valion Bio Inc.
D

VBIO

2.18000
USD
-0.10
(-4.18%)
مغلق
حجم التداول
1,055
الربح لكل سهم
-24
العائد الربحي
-
P/E
-0
حجم السوق
1,934,944
المقالات
المزيد

العنوان: Valion Bio Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.